References
- Shibata N. Transgenic mouse model for familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation. Neuro- pathology 2001; 21(1): 82–92.
- Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med 2001; 344(22): 1688–1700.
- Hirano A. Cytopathology of amyotrophic lateral sclerosis. Adv Neurol 1991; 56: 91–101.
- Przedborski S, Mitsumoto H, Rowland LP. Recent advances in amyotrophic lateral sclerosis research. Curr Neurol Neurosci Rep 2003; 3(1): 70–77.
- Przedborski S, Vila M, Jackson-Lewis V. Series Introduction: Neurodegeneration: what is it and where are we? J Clin Invest 2003; 111(1): 3–10.
- Brown RH Jr. Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice. Cell 1995; 80: 687–692.
- Gue´gan C, Przedborski S. Programmed cell death in amyotrophic lateral sclerosis. J Clin Invest 2003; 111(2): 153–161.
- Vila M, Przedborski S. Neurological diseases: targeting pro- grammed cell death in neurodegenerative diseases. Nat Rev Neurosci 2003; 4(5): 365–375.
- McGeer PL, McGeer EG. Glial cell reactions in neurodegenerative diseases: pathophysiology and therapeutic interventions. Alzheimer Dis Assoc Disord 1998; 12 (Suppl 2): S1–6.
- McGeer PL, McGeer EG. Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve 2002; 26(4): 459–470.
- Hall ED, Oostveen JA, Gurney ME. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia 1998; 23(3): 249–256.
- Almer G, Vukosavic S, Romero N, Przedborski S. Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 1999; 72: 2415–2425.
- Levine JB, Kong J, Nadler M, Xu Z. Astrocytes interact intimately with degenerating motor neurons in mouse amyotrophic lateral sclerosis (ALS). Glia 1999; 28(3): 215–224.
- Almer G, Gue´gan C, Teismann P et al. Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis. Ann Neurol 2001; 49(2): 176–185.
- Drachman DB, Frank K, Dykes-Hoberg M et al. Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS. Ann Neurol 2002; 52(6): 771–778.
- Nguyen MD, Julien JP, Rivest S. Induction of proinflammatory molecules in mice with amyotrophic lateral sclerosis: no requirement for proapoptotic interleukin-1beta in neuro- degeneration. Ann Neurol 2001; 50(5): 630–639.
- Raoul C, Estevez A, Nishimune H et al. Motor neuron death triggered by a specific pathway downstream of Fas. Potentiation by ALS-Linked SOD1 mutations. Neuron 2002; 35(6): 1067–1083.
- Gross A, McDonnell JM, Korsmeyer SJ. BCL-2 family members and the mitochondria in apoptosis. Genes Dev 1999; 13(15): 1899–1911.
- Merry DE, Korsmeyer SJ. Bcl-2 gene family in the nervous system. Annu Rev Neurosci 1997; 20: 245–267.
- Vukosavic S, Dubois-Dauphin M, Romero N, Przedborski S. Bax and Bcl-2 interaction in a transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 1999; 73(6): 2460–2468.
- Kostic V, Jackson-Lewis V, De Bilbao F, Dubois-Dauphin M, Przedborski S. Bcl-2: Prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science 1997; 277(5325): 559–562.
- Li M, Ona VO, Gue´gan C et al. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science 2000; 288(5464): 335–339.